Skip to content
A5179Assembly2021-2022 Session

Require Informed Consent for Psychiatric Drugs

Official title

“Requires a doctor to obtain the informed consent of patients prior to prescribing psychiatric drugs notifying the patient of possible adverse effects of the drug”

Sponsor Michael MontesanoAD-15Affects Education
Status
In Assembly Committee
Higher Education
Impact
5/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Higher Education

What's happening

This bill requires doctors to obtain signed informed consent from patients before prescribing psychiatric drugs, including disclosure of possible adverse effects and drug interactions.

Why it matters

  1. Strengthens patient autonomy. by ensuring individuals are fully informed about potential risks and drug interactions before starting psychiatric medications, allowing for more thoughtful and personal decision-making regarding their mental health treatment.

  2. May affect prescribing practices and workflow. for doctors, who will need to provide detailed explanations and obtain written consent, potentially leading to longer consultations and additional administrative responsibilities.

  3. Could reduce medication-related harm. by requiring explicit disclosure of adverse effects and drug interactions, possibly preventing negative outcomes that occur when patients are unaware of these risks.

  4. Might impact access and timeliness. of psychiatric drug treatments, especially in urgent or crisis situations, by introducing an additional step prior to prescribing, which may delay initiation of needed medications.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Require Informed Consent for Psychiatric Drugs

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Michael Montesano

Assembly Member · Assembly District 15

1 Multi-sponsor

History

  1. Referred to higher education
  2. Held for consideration in higher education
  3. Referred to higher education

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

5179

2021-2022 Regular Sessions

IN ASSEMBLY

February 11, 2021

Introduced by M. of A. MONTESANO -- Multi-Sponsored by -- M. of A. McDO- NOUGH -- read once and referred to the Committee on Higher Education

AN ACT to amend the public health law, in relation to requiring notification and the informed consent of the patient prior to prescribing psychiatric drugs

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The public health law is amended by adding a new section 3346 to read as follows:

§ 3346. Psychiatric drug informed consent. No doctor shall prescribe an antipsychotic, antidepressant, hallucinogen, or mood stabilizer drug, brand or generic, as defined in section thirty-three hundred six of this article, for the treatment of psychiatric disorders or conditions without the prior notification and the signed informed consent of the patient informing the patient of any possible adverse effects of the drug and the interaction with other medications the patient is currently prescribed.

§ 2. This act shall take effect immediately.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD08629-01-1

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.